Hubei Guangji Pharmaceutical: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Hubei Guangji Pharmaceutical: Legal Opinion on Witnessing the 2024 First Extraordinary General Meeting of Shareholders of Hubei Guangji Pharmaceutical Co., Ltd. by Beijing Jing Shi (Wuhan) Law Firm
Hubei Guangji Pharmaceutical: Notice to creditors regarding the reduction of registered capital by repurchasing and canceling restricted stocks.
Hubei Guangji Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hubei Guangji Pharmaceutical: Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Hubei Guangji Pharmaceutical: Beijing Jingshi (Wuhan) Law Firm's witness legal opinion on the 2023 Annual General Meeting of Shareholders of Hubei Guangji Pharmaceutical Co., Ltd.
Hubei Guangji Pharmaceutical: Announcement on the progress of plans to participate in bankruptcy and restructuring investments
Hubei Guangji Pharmaceutical: Internal Control Self-Assessment Report
Hubei Guangji Pharmaceutical: 2023 Annual Financial Report
Hubei Guangji Pharmaceutical: Announcement on preparation for impairment of assets accrued in 2023
Hubei Guangji Pharmaceutical: Notice on Obtaining a Notice of Approval for Supplemental Application for Pantoprazole Sodium Enteric Tablets
Hubei Guangji Pharmaceutical: Notice of Annual General Meeting of Shareholders
Hubei Guangji Pharmaceutical: Special instructions on the proposed non-distribution of profits in 2023
Hubei Guangji Pharmaceutical: 2023 Financial Results Report
Guangji Pharmaceutical: Announcement on the progress of the subsidiary's application for loans and related transactions from the controlling shareholder Sun Company using a patent pledge guarantee
Guangji Pharmaceutical: Announcement on the Appointment of General Manager
Guangji Pharmaceutical: Announcement on the Resignation of the Company\'s Financial Director and Appointment of the Chief Financial Officer
Guangji Pharmaceutical: Announcement on the Appointment of Senior Management
Guangji Pharmaceutical: Progress Announcement on Proposed Participation in Bankruptcy and Reorganization Investments
Guangji Pharmaceutical: Notice to Creditors on Repurchase and Cancellation of Restricted Shares to Reduce Registered Capital
No Data